Sister Study
The Sister Study is a landmark research project initiated by the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH) in the United States. The study is designed to explore the environmental and genetic factors that may influence a woman's risk of developing breast cancer. It is a longitudinal study, meaning it follows its participants over a long period of time to observe how various factors can influence health outcomes.
Background
Breast cancer is one of the most common cancers among women worldwide. Understanding the causes and risk factors for breast cancer is crucial for developing prevention strategies. While it is known that genetic factors play a role in breast cancer risk, the influence of environmental exposures is less clear. The Sister Study was established to fill this gap in knowledge by focusing on women who have sisters diagnosed with breast cancer, as they are at a higher genetic risk of developing the disease themselves.
Study Design
The Sister Study enrolled over 50,000 women aged 35 to 74 who had at least one sister diagnosed with breast cancer but had not been diagnosed themselves. These participants were recruited from across the United States and Puerto Rico. The study collects detailed information on participants' health, lifestyle, and environmental exposures through questionnaires, home visits, and biological samples.
Participants are followed annually through health updates and more detailed questionnaires every 2-3 years. The study aims to identify factors that may increase or decrease the risk of developing breast cancer, including but not limited to dietary habits, physical activity, use of medications and supplements, reproductive history, and exposure to environmental pollutants.
Key Findings
While the Sister Study is ongoing, it has already contributed to significant advancements in understanding breast cancer risk. Some key findings include the identification of genetic markers associated with breast cancer risk, the impact of lifestyle factors such as physical activity and diet on risk, and the role of environmental exposures, including air pollution and chemicals found in everyday products, in breast cancer development.
Importance
The Sister Study is one of the largest and most comprehensive studies focusing on the risks associated with breast cancer. Its longitudinal design and detailed data collection make it a valuable resource for researchers studying not only breast cancer but also other health conditions. The study's findings have the potential to inform public health guidelines and prevention strategies, ultimately reducing the incidence of breast cancer.
Future Directions
As the Sister Study continues, researchers aim to explore more deeply the interactions between genetic predispositions and environmental exposures. The study also plans to investigate the biological mechanisms through which these factors influence breast cancer risk. Additionally, the Sister Study serves as a model for other epidemiological studies focusing on different diseases, showcasing the importance of long-term, detailed data collection in understanding complex health issues.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
